University of Oxford – Confidence in Concept 2019

牛津大学 — 2019 年概念信心

• 批准号: MC_PC_19049
• 负责人: Matthew Wood
• 金额: $ 146.58万
• 依托单位: University of Oxford
• 依托单位国家: 英国
• 项目类别: Intramural
• 财政年份: 2020
• 资助国家: 英国
• 起止时间: 2020 至 无数据
• 项目状态: 已结题
• 来源: https://gtr.ukri.org/projects?ref=MC_PC_19049
• 关键词: University; Oxford; Confidence; Concept; 2019

Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.

目前GtR中并没有所有资助研究的摘要。这通常是因为在提交提案时不需要摘要，但也可能是因为摘要中包含个人详细信息等敏感信息。

项目成果

Tolerability and Efficacy of the Anticluster of Differentiation 47 Antibody Magrolimab Combined With Azacitidine in Patients With Previously Untreated AML: Phase Ib Results.

分化抗体的耐受性和疗效47抗体Magrolimab与阿扎西替丁在先前未经治疗的AML：IB期结果的患者中结合使用。

• DOI: 10.1200/jco.22.02604
• 发表时间: 2023-11-01
• 期刊: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

xTMS: A Pulse Generator for Exploring Transcranial Magnetic Stimulation Therapies.

• DOI: 10.1109/apec43580.2023.10131554
• 发表时间: 2023-05-31
• 期刊: Conference proceedings. IEEE Applied Power Electronics Conference and Exposition
• 作者: Ali K;Wendt K;Sorkhabi MM;Benjaber M;Denison T;Rogers DJ
• 通讯作者: Rogers DJ

TP53-Mutated Myelodysplastic Syndrome and Acute Myeloid Leukemia: Biology, Current Therapy, and Future Directions.

• DOI: 10.1158/2159-8290.cd-22-0332
• 发表时间: 2022-11-02
• 期刊: CANCER DISCOVERY
• 影响因子: 28.2
• 作者: Daver, Naval G.;Maiti, Abhishek;Kadia, Tapan M.;Vyas, Paresh;Majeti, Ravindra;Wei, Andrew H.;Garcia-Manero, Guillermo;Craddock, Charles;Sallman, David A.;Kantarjian, Hagop M.
• 通讯作者: Kantarjian, Hagop M.

Programmable RNA editing with endogenous ADAR enzymes - a feasible option for the treatment of inherited retinal disease?

• DOI: 10.3389/fnmol.2023.1092913
• 发表时间: 2023
• 期刊: FRONTIERS IN MOLECULAR NEUROSCIENCE
• 影响因子: 4.8
• 作者: Bellingrath, Julia-Sophia;McClements, Michelle E. E.;Fischer, M. Dominik;MacLaren, Robert E. E.
• 通讯作者: MacLaren, Robert E. E.

MDS-482 Impact Of Magrolimab in Combination With Azacitidine on Red Blood Cells (RBCs) in Patients With Higher-Risk Myelodysplastic Syndromes (HR MDS)

MDS-482 Magrolimab 联合阿扎胞苷对高危骨髓增生异常综合征 (HR MDS) 患者红细胞 (RBC) 的影响

• DOI: 10.1016/s2152-2650(22)01421-5
• 发表时间: 2022
• 期刊: Clinical Lymphoma Myeloma and Leukemia
• 影响因子: 2.7
• 作者: Chen J